
Oppenheimer raises Marvell target to $110 from $90 ahead of December 3 earnings, maintaining a Buy. Oppenheimer expects Q3 beat and strong Q4 guidance driven by AI computing and networking momentum. While management targets $1.5B/$2.5B in AI-related sales for CY24/25, the analyst sees potential for double current investor expectations ($2B) across four key projects (Trainium, Inferentia, Axion, Maia). Opp notes that project rollout timeline shows steady momentum: Trainium/Axion ramping now (Trainium potentially $2B alone), Inferentia next year, and Maia possible by Q4'25, noting new products ramping with initial revenue contributions: 1.6T PAM4 DSP and 51.2T TL10 switch expected to generate tens of millions in Q4.